The $800 million pill : the truth behind the cost of new drugs /

Afficher d'autres versions (1)

"Drug companies insist that [prescription drug] prices reflect the millions they invest in research and development ... Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying high prices for prescrip...

Description complète

Détails bibliographiques
Cote:Libro Electrónico
Auteur principal: Goozner, Merrill, 1950-
Format: Électronique eBook
Langue:Inglés
Publié: Berkeley : University of California Press, ©2004.
Sujets:
Prescription pricing.
Drugs > Prices.
Pharmaceutical industry.
Consumer education.
Drug Industry > economics
Drug Industry
Biomedical Research > economics
Drug Therapy > economics
Médicaments > Prix.
Industrie pharmaceutique.
Consommateurs > Éducation.
BUSINESS & ECONOMICS > Industries > General.
MEDICAL > Health Care Delivery.
Consumer education
Drugs > Prices
Pharmaceutical industry
Prescription pricing
Arzneimittelforschung
Forschungsausgaben
Arzneimittelpreis
Öffentliche Förderung
Forschungsfinanzierung
Staatliche Einrichtung
Pharmazeutische Industrie
Accès en ligne:Texto completo

Internet

Texto completo

Items no disponibles

Informations d'exemplaires de

Documents similaires